Skip to main content
Parexel

Parexel

Clinical research organization companywww.parexel.com

Search complete. 22 mentions across 5 episodes found for "Parexel".

Oct 10, 2026

speaker_4SOUNDBITE_SPEAKER
2:53
I was in intensive care, fighting for my life, and someone was responsible for that.
speaker_3SOUNDBITE_SPEAKER
3:33
Parexel is a, a large multinational contract research organization.
speaker_3SOUNDBITE_SPEAKER
3:40
They had a site which they leased from Northwick Park Hospital, and they were doing clinical trials independently from the hospital, um, on early phase development of new drugs.
speaker_4SOUNDBITE_SPEAKER
3:51
[instrumental music plays] I was about 31.
speaker_4SOUNDBITE_SPEAKER
4:36
Well, just the scientific contribution I could be making.
David OakleySOUNDBITE_SPEAKER
4:43
When I saw the ad, I was like, 2,000 pounds for three days work seemed like a, a good deal to me, um, considering I'd done two previous trials, and, and it wasn't, it wasn't hard work.
speaker_5SOUNDBITE_SPEAKER
5:05
When I first arrived at the Parexel unit, I was running late.
speaker_5SOUNDBITE_SPEAKER
5:09
I was only 23, so I was a, a baby [laughs].
Dave SunderhaftGUEST
1:34
I've always been in the, uh, the research space, um, and primarily focused on applying technology to processes to improve processes.
Dave SunderhaftGUEST
1:44
Um, but, uh, before I joined, uh, REDCAP Cloud, I was at Parexel for, uh, roughly 11 years and led the eClinical Solutions group there.
Dave SunderhaftGUEST
1:56
Um, was involved...
Dave SunderhaftGUEST
1:57
I don't know if you're familiar with, uh, what Parexel had, but, uh, basically we're the only CRO at the time that had a full eClinical suite of capabilities.
Dave SunderhaftGUEST
2:06
So, uh, we had, uh, ClinPhone RTSM, which was the leader in randomization trial supply management, Impact CTMS, uh, which was the leader, um, in the CTMS solutions.
Dave SunderhaftGUEST
2:18
We had Datlab EDC, uh, and many other technologies.
Dave SunderhaftGUEST
2:27
And at the time there were a lot of, uh, drugs coming off patent like Lipitor, Pfizer.
Dave SunderhaftGUEST
2:33
And so, you know, big pharma, a lot of large pharma organizations need to figure, needed to figure out how to get, uh, their costs in line with their revenue.
speaker_4SOUNDBITE_SPEAKER
2:00
[tense music] [birds chirping]
speaker_3SOUNDBITE_SPEAKER
2:33
Parexel is, uh, a large multinational contract research organization.
speaker_3SOUNDBITE_SPEAKER
2:40
They had a site which they leased from Northwick Park Hospital, and they were doing clinical trials independently from the hospital, um, on early phase development of new drugs.
speaker_3SOUNDBITE_SPEAKER
2:50
[tense music] [birds chirping]
DavidSOUNDBITE_SPEAKER
3:43
When I saw the ad, I was like, £2,000 for three days' work seemed like a, a good deal to me, um, considering I'd done two previous trials and, and it wasn't, it wasn't hard work.
DavidSOUNDBITE_SPEAKER
3:56
[tense music]
speaker_5SOUNDBITE_SPEAKER
4:04
When I first arrived at the Parexel unit, I was running late.
speaker_5SOUNDBITE_SPEAKER
4:08
I was only 23, so I was a, a baby, [laughs] and, uh, I just finished university.
Jay MenasheHOST
0:25
My guest today has spent over three decades inside the exact environment most marketers are afraid of, the most regulated corner of experiential, pharma and biotech commercialization.
Jay MenasheHOST
0:36
Michael Young is the principal and founder of BioMedWorks, Life Sciences Consulting, and before going independent, he ran global oncology strategy at Eisai and led alliance and business development at PPD and Parexel.
Jay MenasheHOST
0:48
He was named medical marketer of the year and later became president of that same organization.
Jay MenasheHOST
0:52
But here's what makes him different from almost every other guest we've had on this show.
speaker_2GUEST
2:25
[birds chirping]
speaker_3GUEST
2:25
Parexel is a, a large multinational contract research organization.
speaker_3GUEST
2:32
They had a site which they leased from Northwick Park Hospital, and they were doing clinical trials independently from the hospital, um, on early phase development of new drugs.
speaker_3GUEST
2:42
[tense music] [door creaking]
speaker_2GUEST
3:21
I was interested in the, the kind of historical... [sighs] Well, just the scientific contribution I could be making.
speaker_0GUEST
3:35
When I saw the ad, I was like, £2,000 for three days work seemed like a, a good deal to me, um, considering I'd done two previous trials and, and it wasn't, it wasn't hard work.
DavidGUEST
3:56
When I first arrived at the Parexel unit, I was running late.
DavidGUEST
4:00
I was only 23, so I was a, a baby.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.